Updated:
Baxter Health Enlon Products
Baxter Health Enlon Products manufactures Enlon (edrophonium chloride) for anesthesia reversal. Part of Baxter International, based in Deerfield.
Baxter Health Enlon Products
Baxter Health Enlon Products is a product line within Baxter International, a global healthcare company founded in 1931. Enlon is the brand name for edrophonium chloride, a drug used to reverse the effects of non-depolarizing neuromuscular blocking agents after surgery. This product line is one of many in Baxter's Medication Delivery segment. Strategy is production and distribution of generic injectable drugs for hospital use. Baxter's medication delivery business manufactures over 170 different products, including IV solutions, infusion systems, and anesthesia drugs. Enlon competes in the neuromuscular blockade reversal market alongside products from other generic manufacturers. Distribution reaches US hospitals and healthcare facilities. Baxter International reported 2025 revenue of approximately $14.8 billion globally, but no breakdown is available for the Enlon product line specifically. The product is manufactured at Baxter facilities, likely in the US or Ireland. No distinct team size or leadership is publicly associated with this product line alone. Baxter Health Enlon Products exists as a discrete SKU within a publicly traded global corporation, not as a standalone investment or entity. Its structural differentiator is status as a generic drug product subject to FDA regulation and pricing pressures typical of the hospital pharmaceutical market.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Deerfield
Corporate office
Deerfield, United States
Sector focus
Frequently asked questions
What is Enlon used for?
Enlon (edrophonium chloride) is a drug used to reverse the effects of non-depolarizing neuromuscular blocking agents. It is administered by anesthesiologists after surgery to restore normal muscle function in patients who have received muscle relaxants.
Is Baxter Health Enlon Products a separate company from Baxter International?
No. Baxter Health Enlon Products is a product line within Baxter International, a publicly traded healthcare company. It is not a separate legal entity, family office, or investment vehicle.
Who manufactures Enlon?
Enlon is manufactured by Baxter International, likely at one of its pharmaceutical production facilities in the United States or Ireland. Baxter is one of several manufacturers of edrophonium chloride for the US market.
What is the market for neuromuscular blocking reversal agents?
The market includes drugs like neostigmine, sugammadex (Bridion), and edrophonium. Enlon competes primarily with neostigmine and sugammadex in US hospitals. The total US market for such agents is estimated at several hundred million dollars annually.
Why is Baxter Health Enlon Products listed as a family office?
It is not a family office. The listing is a data categorization error in the Altss record. Baxter Health Enlon Products is a pharmaceutical product line, not an investment or wealth management entity.
Does Baxter Health Enlon Products have any publicly listed AUM or investment strategy?
No. The entity has no AUM or investment operations. It is a commercial product within a larger corporation's regulated drug portfolio.
How can I find financial data for the Enlon product line?
Baxter International does not publicly disclose product-level revenue for older generic drugs like Enlon. Financial data is aggregated in Baxter's Medication Delivery segment reports, available in SEC filings.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: